Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
70.78198
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
0
29,158
14,752.7422
16,568.5469
16.666656
white
13.898438
20
0.899902
0.863892
1
1
0
no
0.5
0.5
no dnr
20
73
11.298828
80
20
37.79688
null
null
0.399963
1
138
null
130
19
null
1
0
<2 mo. follow-up
0
31
1
82.034
female
1
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
null
9
27,756
7,517.25
23,028.2188
23
black
33.898438
76
0.407959
0.28894
4
0
0
no
0.5
0.4
dnr after sadm
2
66
6.399414
70
40
36.09375
80
2.699707
0.5
3.399902
138
7.439453
247
85
860
null
5
<2 mo. follow-up
5
10
1
82.55396
female
1
18
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
0
58,079
57,121.4375
53,527.0312
26.666656
white
33.796875
68
0.416992
0.297974
9
0
1
no
0.9
0.75
dnr after sadm
10
107
7.699219
80
24
38
null
null
null
1
135
null
275
16
975
null
null
<2 mo. follow-up
5.213867
18
1
84.01898
male
0
3
CHF
COPD/CHF/Cirrhosis
4
14
$25-$50k
0
3,200
1,747.9268
1,724.50977
null
white
18.097656
34
0.822998
0.711914
1
0
0
no
0.9
0.8
no dnr
3
100
11.099609
100
20
37
null
null
null
0.599976
136
null
172
11
null
null
null
no(M2 and SIP pres)
2.732422
887
1
80.02698
female
0
18
COPD
COPD/CHF/Cirrhosis
3
12
null
0
29,207
11,660.3984
22,357.7344
24.333328
white
28.199219
40
0.5979
0.407959
2
0
0
no
0.6
0.6
no dnr
18
103
33
60
15
37
null
3.099609
1.5
0.799927
152
7.539062
176
13
54.5
0
0
no(M2 and SIP pres)
0
792
1
75.31598
female
0
30
Coma
Coma
0
12
under $11k
100
34,680
20,164.875
27,403.6406
17.5
black
14.798828
19
0.368958
0.295959
1
0
0
no
0.25
0.1
dnr after sadm
2
57
11.599609
80
20
37.29688
null
null
1.199951
1.199951
133
null
328
23
null
null
1
adl>=4 (>=5 if sur)
1
68
1
76.487
male
0
12
Cirrhosis
COPD/CHF/Cirrhosis
5
15
null
9
17,185
9,153.4531
8,645.51562
9
white
14.099609
28
0.708984
0.547974
1
0
0
yes
0.75
0.6
dnr after sadm
1
57
2.599609
114
32
37.79688
null
3.299805
4.599609
2.199707
135
null
98
31
350
null
0
SIP>=30
0
78
1
68.97998
male
0
3
COPD
COPD/CHF/Cirrhosis
6
12
under $11k
0
4,894
2,226.7188
2,818.84961
null
white
14.398438
34
0.872925
0.789917
1
0
0
yes
0.8
0.75
no dnr
3
83
14.5
100
25
36.09375
null
2.699707
null
0.899902
135
null
157
24
null
1
2
SIP>=30
2
387
1
67.45795
female
0
8
Lung Cancer
Cancer
1
14
under $11k
0
8,469
4,488.4531
6,305.9375
12.5
white
23
26
0.56189
0.238983
1
0
0
metastatic
0.3
0.1
no dnr
8
99
26.898438
68
20
37.69531
281.625
3
0.5
0.899902
141
7.269531
171
20
null
0
0
SIP>=30
0
121
1
64.30096
female
0
5
Colon Cancer
Cancer
2
16
>$50k
0
5,613
3,166.1211
715.5498
13
white
27.5
15
0.625
0.311951
1
0
0
metastatic
0.9
0.6
no dnr
5
49
13.599609
121
36
37.69531
316.625
3.199707
3.299805
5.099609
145
7.379883
155
8.798828
860
0
0
no(M2 and SIP pres)
0
1,020
0
87.25299
female
0
14
COPD
COPD/CHF/Cirrhosis
1
12
null
0
22,466
10,451.4688
14,536.5156
10
white
18.296875
29
0.743896
0.5979
2
0
0
no
0.75
0.7
no dnr
14
60
13.699219
120
44
38.19531
231.65625
null
0.599976
1.099854
150
7.329102
233
23
1,166
0
0
SIP>=30
0
1,006
1
73.92694
male
0
9
CHF
COPD/CHF/Cirrhosis
6
16
under $11k
0
14,982
7,797.0742
8,092.72656
7.5
white
26.199219
45
0.740967
0.592896
1
0
0
no
0.76
0.6
dnr before sadm
-1
73
9.699219
65
8
38.59375
122.5
null
null
1.399902
143
7.179688
265
36
1,005
2
0
SIP>=30
0
93
1
81.85095
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
52,814
30,049.1719
36,880.8438
40.666657
white
43.296875
59
0.241974
0.139984
1
0
0
no
0.1
0.05
no dnr
20
47
9.599609
70
24
37.89844
162.84375
1.899902
null
0.699951
139
7.319336
178
19
1,255
null
0
no(M2 and SIP pres)
0
726
1
72.52594
female
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
64,956
24,196.6562
35,415.6875
27
black
30.5
22
0.655884
0.557983
1
1
0
no
0.02
0
no dnr
26
55
9.898438
112
40
38.19531
165.28125
4.199219
0.599976
1.099854
136
7.30957
282
24
1,930
null
0
adl>=4 (>=5 if sur)
0
1,018
0
72.35895
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
33,427
13,770.5
28,687.7031
18.666656
white
17.398438
25
0.855957
0.805908
2
0
0
no
0.8
0.8
no dnr
20
109
10.599609
82
20
37.79688
373.3125
2.399902
0.899902
1.199951
141
7.399414
101
28
2,350
0
0
no(M2 and SIP pres)
0
446
1
83.49896
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
>$50k
9
30,052
14,490.6094
14,161.5469
15
white
34.09375
72
0.366943
0.248993
1
0
0
yes
0.2
0.1
dnr after sadm
1
111
7
58
28
33.79688
388
2.399902
4.5
5.5
135
7.25
80
56
48
null
2
<2 mo. follow-up
2
8
1
77.35797
male
0
8
MOSF w/Malig
ARF/MOSF
2
12
>$50k
0
12,651
5,684.1094
5,677.72656
19
white
27.898438
34
0.588989
0.47998
1
1
0
yes
0.9
0.9
no dnr
8
57
6.099609
120
40
37.69531
94
null
null
1.399902
148
7.379883
140
66
758
0
2
no(M2 and SIP pres)
2
1,015
0
61.81198
female
0
20
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
0
48,864
32,935.75
33,247.5312
28.666656
white
27.097656
41
0.792969
0.666992
1
1
0
no
0.9
0.85
no dnr
20
107
3.899902
60
20
36.69531
447.5625
4.099609
null
5.099609
138
7.379883
79
42
1,850
null
2
no(M2 and SIP pres)
2
1,015
0
85.172
male
1
4
MOSF w/Malig
ARF/MOSF
2
20
>$50k
0
12,742
8,474.7344
7,543.33984
36
white
36.195313
69
0.337952
0.221985
1
0
0
yes
0.05
0
dnr before sadm
-1
66
17.398438
120
33
37.69531
135
3.199707
null
1.299805
140
7.449219
118
43
1,340
null
null
<2 mo. follow-up
2.780762
4
1
77.63995
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
100
19,449
6,839.2773
15,846.9766
19
black
24.5
49
0.256958
0.151978
3
1
0
no
null
null
dnr after sadm
6
100
null
80
30
39.39844
null
null
null
null
140
null
null
null
600
null
null
<2 mo. follow-up
3.683594
7
1
69.33899
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$11-$25k
0
54,183
16,196.5078
42,575
39.666657
white
27
39
0.702881
0.612915
4
0
0
no
0.5
0.5
no dnr
16
103
5.599609
80
20
37.79688
423.75
2.199707
1.799805
1.299805
145
7.469727
109
26
500
null
1
<2 mo. follow-up
1
23
1
35.116
male
1
13
ARF/MOSF w/Sepsis
ARF/MOSF
3
20
under $11k
0
38,566
14,847.1406
34,751.5
31
black
26.699219
43
0.860962
0.81189
1
0
0
no
0.8
0.8
dnr after sadm
4
76
6.899414
72
26
36.5
304
3.699707
null
1.099854
143
7.469727
96
10
1,490
null
6
<2 mo. follow-up
6
13
1
91.93396
female
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
15
under $11k
44
95,204
62,915.8125
57,928.5
35
white
32
58
0.163971
0.081985
17
0
0
no
0.15
0.1
dnr after sadm
1
65
6.299805
108
26
37.09375
146.9375
null
null
null
140
7.329102
96
17
1,800
null
2
<2 mo. follow-up
2
15
1
81.29999
female
0
7
COPD
COPD/CHF/Cirrhosis
2
6
under $11k
0
7,211
4,100.0664
4,032.4082
5
white
20.097656
34
0.772949
0.637939
1
0
0
no
0.5
0.5
dnr after sadm
1
83
2.399902
60
20
36.29688
null
2.5
1.099854
0.899902
141
null
89
4
950
null
null
SIP>=30
3.75293
1,011
0
57.61298
female
0
4
Lung Cancer
Cancer
1
14
>$50k
0
13,214
6,605.2031
2,559.75977
16
white
12.199219
5
0.804932
0.583984
1
0
0
metastatic
0.9
0.7
no dnr
4
101
18.296875
69
20
36.29688
249
3.899902
null
1.5
140
7.179688
203
47
2,650
0
null
no(M2 and SIP pres)
0.494751
772
1
83.74799
female
0
5
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
0
5,225
2,941.1777
3,058.41992
12
white
17.699219
31
0.744995
0.598999
1
0
0
yes
0.8
0.5
no dnr
5
67
17
100
25
36.39844
264
3.399902
1.099854
2.599609
136
7.429688
145
77
null
0
null
no(M2 and SIP pres)
0.494751
951
1
81.50897
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
2
17
>$50k
9
23,306
12,391.3984
14,378.75
12.333328
white
20.398438
38
0.777954
0.706909
1
0
1
no
0.75
0.75
no dnr
17
37
8.398438
56
8
38.59375
63
3.099609
1.299805
2.199707
136
7.339844
109
37
1,530
null
6
adl>=4 (>=5 if sur)
6
1,007
0
74.26697
male
0
19
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
26,839
13,803.5078
17,275.8594
12
white
19
36
0.831909
0.724976
1
0
0
no
0.8
0.8
no dnr
19
43
6.099609
105
8
38.39844
317.5
null
0.399963
0.5
147
7.399414
276
10
2,975
0
null
adl>=4 (>=5 if sur)
0.494751
199
1
75.98596
male
0
39
Lung Cancer
Cancer
2
null
null
0
51,147
27,488.625
29,141.6875
10
white
7.399414
20
0.837891
0.645996
1
0
0
metastatic
0.9
0.6
dnr after sadm
26
110
8.5
60
36
38.89844
254
2.799805
null
0.799927
134
7.419922
120
16
2,400
null
null
null
2.621094
122
1
87.59497
female
1
23
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
53,912
18,908.0312
41,129.9062
23.333328
white
14.099609
29
0.820923
0.708984
1
0
0
no
0.5
0.2
no dnr
23
56
0.699951
102
30
39.19531
251.65625
null
1
2.399902
135
7.5
93
44
780
null
7
<2 mo. follow-up
7
23
1
80.77197
female
0
9
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
12,938
6,714.7852
7,052.87891
10.5
white
16.398438
21
0.828979
0.721924
1
0
0
no
0.9
0.7
no dnr
9
55
4.699219
55
38
35.19531
280
3.399902
0.799927
0.899902
139
7.539062
196
10
2,050
1
0
SIP>=30
0
248
1
79.36499
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
15,161
11,720.0547
12,239.0781
16
white
19.898438
31
0.816895
0.755981
1
0
0
no
0.4
0.3
dnr after sadm
1
63
15.298828
60
8
37.79688
68.75
null
2
1.199951
135
7.439453
213
47
2,500
null
null
<2 mo. follow-up
2.866699
39
1
42.98199
male
0
8
CHF
COPD/CHF/Cirrhosis
3
16
>$50k
0
8,715
4,783.1445
5,150.4375
10.5
white
29.5
43
0.819946
0.707886
1
0
0
no
0.9
0.75
no dnr
8
58
2.299805
134
40
39.09375
484
null
null
3.699707
136
7.439453
80
108
1,935
1
2
<2 mo. follow-up
2
50
1
51.64999
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
33,418
11,204.1328
26,288.0469
22.666656
white
25.097656
37
0.833984
0.777954
1
0
0
no
0.9
0.9
no dnr
14
52
10.599609
70
8
38.09375
196
2.299805
null
1.899902
145
7.429688
315
37
1,610
null
0
no(M2 and SIP pres)
0
1,004
0
78.64496
female
0
8
Colon Cancer
Cancer
2
12
null
0
7,249
4,118.5742
5,068.64844
2
white
15.099609
11
0.817993
0.60791
1
1
0
metastatic
0.8
0.4
no dnr
8
65
12.5
150
14
35.39844
null
null
0.799927
1.699951
144
null
145
21
4,345
0
1
adl>=4 (>=5 if sur)
1
1,003
0
55.48297
male
0
4
Lung Cancer
Cancer
1
12
>$50k
0
15,966
8,098.7812
3,559.55859
14
white
15.099609
5
0.763916
0.513916
1
0
0
metastatic
0.95
0.6
no dnr
4
142
15.099609
50
24
36.19531
null
2.199707
1.899902
3.099609
141
null
167
46
1,990
null
null
no(M2 and SIP pres)
1.988281
692
1
39.784
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
23,300
8,672.8906
14,412.8594
52
white
35.796875
77
0.709961
0.621948
1
0
0
no
0.5
0.5
no dnr
5
73
22.597656
110
14
36.69531
190
1.399902
null
4
129
7.369141
77
62
1,460
null
0
<2 mo. follow-up
0
5
1
68.31195
female
1
10
CHF
COPD/CHF/Cirrhosis
3
9
under $11k
9
11,437
6,671.9297
6,360.73828
16.5
white
38
51
0.455994
0.254944
1
0
0
no
0.1
0
dnr after sadm
2
107
11.398438
70
20
37.79688
171.40625
null
null
1.699951
143
7.389648
107
31
null
null
6
<2 mo. follow-up
6
10
1
42.74597
male
0
9
Cirrhosis
COPD/CHF/Cirrhosis
3
16
>$50k
0
11,712
5,439.4219
8,912.85938
10
white
19.5
33
0.842896
0.74292
1
0
0
yes
0.95
0.75
no dnr
9
85
3.599609
72
16
37.39844
null
3.599609
0.899902
0.899902
137
null
114
9
3,200
0
0
no(M2 and SIP pres)
0
998
0
82.70496
female
0
7
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
0
7,815
3,563.9981
5,032.76953
5.5
white
17.097656
29
0.80896
0.690918
1
0
0
no
0.5
0.3
no dnr
7
103
6.799805
100
25
36.69531
229.625
null
null
1.199951
137
7.379883
92
24
1,575
1
null
no(M2 and SIP pres)
1.166748
473
1
65.10095
female
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
15
under $11k
0
19,496
11,600.2734
7,061.74609
17.5
hispanic
18.597656
14
0.869995
0.824951
1
0
0
no
0.95
0.95
no dnr
12
120
10.099609
51
26
37.89844
242.84375
3.199707
0.299988
1.599854
149
7.459961
86
44
null
0
null
null
0.494751
518
1
77.68097
female
0
7
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
7,278
4,078.0527
4,712.27734
6.5
white
13.699219
35
0.872925
0.78894
1
0
0
no
0.8
0.6
dnr before sadm
-1
67
10.5
80
20
36.09375
256
3.299805
null
1.599854
140
7.459961
95
23
5,000
null
2
<2 mo. follow-up
2
26
1
47.12097
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
2
11
under $11k
0
18,732
7,620.1289
14,185.4062
24.5
white
29.5
44
0.707886
0.547974
1
0
0
no
0.77
0.8
no dnr
8
107
7.299805
100
25
38.89844
null
4.399414
0.899902
0.799927
136
null
197
13
1,950
0
2
SIP>=30
2
212
1
50.60098
male
0
4
COPD
COPD/CHF/Cirrhosis
2
null
null
0
5,799
3,000.6602
3,188.38867
15
white
14.398438
8
0.945923
0.906982
1
0
0
no
0.9
0.85
no dnr
4
65
9.398438
72
8
36.59375
197.5
2.799805
0.399963
1
137
7.369141
132
49
1,020
null
null
null
2.116211
996
0
89.70795
female
1
4
Coma
Coma
3
12
under $11k
44
4,730
2,593.6152
2,530.62891
11
white
26.199219
41
0.11499
0.070999
1
1
1
yes
null
null
dnr before sadm
-1
93
10.199219
80
20
36.09375
285.6875
null
null
1.299805
143
7.40918
109
31
575
null
null
<2 mo. follow-up
5.073242
4
1
44.58899
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
$11-$25k
0
43,026
29,745.9531
30,139.8594
36.5
white
22.699219
41
0.87793
0.834961
1
0
0
no
0.85
0.8
no dnr
13
102
5.299805
73
30
37.59375
176.65625
null
0.299988
1
134
7.369141
508
26
1,760
null
0
no(M2 and SIP pres)
0
67
1
23.33499
female
1
22
MOSF w/Malig
ARF/MOSF
3
13
under $11k
0
118,566
40,615.4688
68,099
44.333313
white
33.398438
59
0.539917
0.424988
1
0
0
yes
0.9
0.6
dnr after sadm
21
47
6.599609
120
35
36.69531
null
null
null
1.299805
138
null
99
21
null
null
0
<2 mo. follow-up
0
22
1
57.629
female
0
17
Cirrhosis
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
36,754
14,798.7344
21,377.7344
30.666656
white
41.398438
40
0.28894
0.11499
1
0
0
no
0.5
0.35
no dnr
17
58
21.199219
99
24
37
132.5
null
0.5
0.799927
137
7.329102
230
10
1,990
null
0
no(M2 and SIP pres)
0
994
0
83.75397
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
100
21,739
7,108.4688
17,372.0938
28.5
white
20.199219
33
0.387939
0.268982
1
1
1
no
0.8
0.5
no dnr
11
113
null
68
20
36.19531
null
null
null
null
140
null
null
null
1,100
null
null
null
6.509766
128
1
44.64297
male
0
14
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
39,916
29,562.3125
26,730.5781
27.333328
black
33.59375
45
0.751953
0.60791
1
0
0
no
0.5
0.5
no dnr
14
97
6.099609
64
16
36.69531
null
null
0.899902
1.299805
141
null
189
16
null
7
4
<2 mo. follow-up
4
39
1
89.23999
female
0
6
CHF
COPD/CHF/Cirrhosis
3
14
under $11k
0
5,975
3,379.2207
3,369.35938
6
white
14.699219
35
0.810913
0.692993
1
0
0
yes
0.95
0.9
dnr before sadm
-1
55
25.796875
139
26
39.29688
67
1.899902
0.799927
0.899902
144
7.319336
72
42
1,193
0
0
SIP>=30
0
666
1
40.73599
male
0
11
Cirrhosis
COPD/CHF/Cirrhosis
2
null
null
0
20,281
9,646.7969
11,787.3359
13
white
22.796875
50
0.835938
0.731934
2
0
0
no
0.5
0.3
no dnr
11
43
80
50
20
37.79688
null
3
0.599976
2.5
139
null
100
115
625
null
null
null
2.804688
991
0
89.5
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
14,752
8,761.9141
8,936.48438
13
white
22.898438
33
0.730957
0.647949
1
0
0
no
0.8
0.7
no dnr
7
71
5.299805
110
21
37.5
null
3.399902
3.799805
1
138
null
92
20
1,850
2
2
no(M2 and SIP pres)
2
990
0
83.98395
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
5
8
under $11k
0
13,372
8,229.1406
8,197.4375
13
white
20.796875
36
0.787964
0.718994
1
0
1
no
0.25
0.2
dnr after sadm
2
59
10.398438
68
26
36.39844
320
3.699707
0.799927
1.099854
134
7.30957
103
19
2,030
null
null
no(M2 and SIP pres)
6.015625
989
0
77.92694
female
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
under $11k
0
25,184
17,107.1406
10,980.3984
15.666664
white
24.097656
47
0.757935
0.681885
1
0
0
no
0.75
0.75
no dnr
17
122
6.699219
76
16
36.89844
151.65625
4.099609
null
1.099854
140
7.459961
96
18
3,570
1
0
no(M2 and SIP pres)
0
684
1
64.28198
female
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
18,119
9,395.9844
9,250.41406
12.5
white
23.597656
45
0.814941
0.75293
1
1
0
no
0.9
0.9
no dnr
12
109
13
100
34
37.69531
251.84375
3.799805
null
1.099854
137
7.329102
250
34
1,100
1
1
SIP>=30
1
986
0
61.823
female
0
42
Coma
Coma
0
18
>$50k
100
73,012
27,574.4219
58,063.625
31.25
hispanic
23.796875
42
0.241974
0.175995
1
0
0
no
0.3
0.3
no dnr
42
52
1.099854
64
30
36.29688
null
2.5
7.899414
0.599976
139
null
110
15
1,040
null
0
Coma or Intub
0
315
1
28.25999
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
null
0
30,418
13,484.6328
19,141.8281
20.5
white
28.5
25
0.826904
0.768921
6
0
0
no
0.9
0.9
no dnr
10
83
5.699219
60
20
35.59375
239.125
4
0.5
0.899902
138
7.369141
171
11
null
5
0
no(M2 and SIP pres)
0
984
0
83.11798
female
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
24,810
11,643.9219
15,341.6094
18.333328
white
34.796875
62
0.481995
0.363953
1
1
0
no
0.5
0.4
no dnr
18
77
26.097656
60
32
36.09375
361.875
3.299805
1.299805
2.399902
145
7.489258
330
37
null
0
0
SIP>=30
0
97
1
59.41998
female
0
9
Colon Cancer
Cancer
1
19
under $11k
0
14,652
7,374.5117
8,592.04688
4
white
22.296875
26
0.746948
0.484985
1
0
0
metastatic
1
0.8
no dnr
9
57
13.199219
120
12
39.19531
266
4.699219
0.399963
0.799927
138
7.399414
129
8
1,180
0
0
no(M2 and SIP pres)
0
785
1
67.06396
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
under $11k
0
36,505
24,395.2812
24,018.8594
24
white
31.097656
42
0.671997
0.575928
1
0
0
no
0.85
0.8
no dnr
14
126
8.199219
134
25
38.09375
152
3.399902
2
3.399902
130
7.389648
167
58
1,971
null
1
no(M2 and SIP pres)
1
982
0
78.94598
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
67,914
41,837.125
44,909.9375
31.666656
white
39.5
50
0.323975
0.209991
3
1
0
no
0.7
0.343
no dnr
20
48
15.298828
106
8
36.19531
113.75
2.5
6.299805
1.399902
149
7.469727
165
18
2,235
null
null
null
2.676758
552
1
43.42499
male
0
6
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
6,695
3,467.9668
3,603.33984
14
black
23.199219
10
0.886963
0.81189
1
0
0
no
0.95
0.9
no dnr
6
51
14.798828
68
8
38.59375
262.5
2.699707
0.299988
0.899902
140
7.40918
321
26
1,080
3
null
SIP>=30
2.510742
980
0
46.80099
male
0
18
Cirrhosis
COPD/CHF/Cirrhosis
2
16
under $11k
9
26,374
14,535.5391
14,160.9844
12
white
37.5
56
0.474976
0.272949
1
0
0
no
0.5
0.3
dnr after sadm
15
66
7.899414
108
26
35.89844
286.625
2.399902
null
1.799805
126
7.5
184
45
2,500
3
null
<2 mo. follow-up
2.510742
55
1
71.31799
male
0
9
Cirrhosis
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
12,882
6,878.3906
6,728.38672
6
white
20.5
33
0.708984
0.54895
1
1
0
no
0.5
0.5
dnr before sadm
0
93
5.599609
60
15
36.09375
318.3125
4.399414
null
2
139
7.359375
108
34
370
0
0
no(M2 and SIP pres)
0
135
1
62.29398
female
0
20
COPD
COPD/CHF/Cirrhosis
4
null
null
0
34,399
15,657.6719
22,460.75
14.333328
white
21.597656
19
0.859985
0.768921
1
0
0
no
0.88
0.77
dnr before sadm
-1
67
16.796875
80
20
38.39844
null
2
15.599609
1.5
142
null
65
33
1,370
null
null
null
3.70459
78
1
41.008
male
0
7
Cirrhosis
COPD/CHF/Cirrhosis
4
15
under $11k
0
16,407
7,312.7578
10,987.6875
8
white
17.898438
34
0.893921
0.822998
1
0
0
no
0.9
0.7
no dnr
7
110
5.899414
60
16
36.19531
297.125
4.699219
0.599976
2.299805
144
7.419922
107
45
1,795
0
null
no(M2 and SIP pres)
0.494751
974
0
53.03198
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
20
$25-$50k
0
19,707
7,497.7969
13,036.8125
23.5
white
22.5
40
0.849976
0.79895
2
0
0
no
0.95
0.95
no dnr
10
62
7.199219
42
16
36.09375
319
null
null
1.5
139
7.379883
125
35
1,170
0
0
no(M2 and SIP pres)
0
973
0
95.60596
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
4
null
0
10,736
4,586.8047
7,526.32812
10.5
white
25.296875
19
0.578979
0.467957
1
0
0
yes
0.5
0.4
dnr before sadm
-1
74
10.398438
62
10
38.09375
373.3125
2.799805
0.5
5.699219
132
7.229492
104
78
1,510
0
1
no(M2 and SIP pres)
1
972
0
62.88599
female
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$25-$50k
9
12,771
4,837.4727
7,684.82812
14
white
20.898438
30
0.833984
0.776978
1
0
0
no
0.8
0.7
no dnr
4
127
10.298828
120
35
40
204.75
3.399902
0.599976
1.099854
139
7.429688
151
12
2,300
0
4
no(M2 and SIP pres)
4
332
1
62.12698
female
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$25-$50k
0
52,812
38,622.9062
38,980.4062
33.666657
hispanic
18.796875
23
0.865967
0.819946
2
1
0
no
0.8
0.6
no dnr
23
153
14.599609
125
36
39.59375
438.0625
2.899902
null
1.199951
134
7.5
220
16
1,055
null
0
adl>=4 (>=5 if sur)
0
971
0
50.82498
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
23,926
13,897.9531
14,176.3047
6.5
black
28.398438
29
0.684937
0.591919
7
0
0
yes
0.65
0.35
dnr before sadm
0
111
14
110
44
37.89844
136.65625
null
null
0.599976
141
7.399414
93
18
3,400
2
6
<2 mo. follow-up
6
49
1
77.26495
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
$11-$25k
37
28,082
10,635.9766
24,002.6562
38.5
white
40
63
0.184998
0.095993
1
0
0
no
0.3
0.3
dnr after sadm
5
55
12.398438
114
30
38.69531
136.71875
3.799805
0.699951
2.699707
136
7.459961
262
61
1,156
null
4
<2 mo. follow-up
4
11
1
44.92297
female
1
9
MOSF w/Malig
ARF/MOSF
1
16
$11-$25k
0
23,066
7,157.0508
19,547.0938
39
white
29.097656
48
0.536987
0.421997
1
0
0
metastatic
0.3
0.1
dnr after sadm
7
103
16.296875
120
25
38.89844
null
null
null
0.799927
135
null
154
11
1,795
null
null
<2 mo. follow-up
2.438477
9
1
49.85397
male
1
7
MOSF w/Malig
ARF/MOSF
1
24
>$50k
0
39,151
16,444.9531
22,753.8125
39.5
white
28.796875
46
0.457947
0.338989
6
0
0
metastatic
0.25
0.15
dnr after sadm
5
57
11.798828
120
26
39.19531
128
2.799805
0.599976
0.799927
133
7.419922
128
9
2,279
null
0
<2 mo. follow-up
0
7
1
88.81598
female
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
9
8,938
4,971.3711
4,022.48828
13
white
22.796875
19
0.704956
0.615967
1
1
1
no
0.8
0.5
no dnr
4
43
17.296875
130
14
38.69531
140
null
null
1.799805
136
7.30957
189
27
1,300
null
null
adl>=4 (>=5 if sur)
6.263672
965
0
90.76794
female
0
15
COPD
COPD/CHF/Cirrhosis
1
12
under $11k
0
27,955
10,796.5703
23,236.2188
21.333328
white
19.398438
41
0.712891
0.553955
1
0
0
no
0.5
0.4
dnr after sadm
3
80
6.399414
80
20
35.59375
347.5625
2.299805
0.799927
1.199951
139
7.369141
113
14
3,400
null
2
adl>=4 (>=5 if sur)
2
742
1
94.07495
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
under $11k
0
13,122
7,737.0781
3,572.13867
18
white
26.097656
25
0.640991
0.53894
1
0
1
no
0.7
0.5
dnr after sadm
1
50
13.599609
110
20
36.09375
null
2.199707
11.298828
0.699951
130
null
157
13
850
null
1
null
1
726
1
61.91397
female
1
22
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
$11-$25k
0
69,577
26,139.0625
48,763.75
37
white
24.898438
61
0.751953
0.672974
9
0
0
no
0.3
0.3
dnr after sadm
18
73
2.799805
80
20
36.09375
null
2
3.5
0.699951
131
null
294
13
null
null
7
<2 mo. follow-up
7
22
1
68.60797
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
>$50k
0
85,343
46,375.0312
59,210.5
23
white
23.898438
53
0.744995
0.664917
8
0
0
no
0.8
0.8
no dnr
19
100
12.398438
108
32
36.59375
225.6875
null
null
0.699951
141
7.379883
202
10
2,280
null
0
null
0
961
0
62.327
male
1
4
Lung Cancer
Cancer
2
null
null
0
4,703
2,592.9492
2,374.42969
9
white
39.09375
37
0.131989
0.007
1
1
0
metastatic
0.05
0.01
dnr before sadm
-1
57
8.199219
74
24
37.79688
null
null
null
1.299805
130
null
169
39
900
null
null
<2 mo. follow-up
2.736328
4
1
77.86694
female
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
41
7,696
3,119.4824
7,546.54688
33
white
44.898438
80
0.031998
0.007999
1
1
0
yes
0.1
0.07
dnr after sadm
2
60
8.798828
52
50
38.79688
171
2.599609
0.699951
0.899902
141
7.369141
96
14
3,450
null
null
<2 mo. follow-up
3.519531
4
1
32.84598
female
0
30
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
79,142
31,164.3906
49,507.875
27.75
hispanic
21.796875
29
0.896973
0.858887
3
0
0
no
0.9
0.9
no dnr
30
100
12.898438
70
20
35.89844
357.125
3.799805
1.099854
0.699951
125
7.509766
237
14
null
null
0
no(M2 and SIP pres)
0
956
0
70.70795
male
0
35
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
$11-$25k
0
165,432
96,053.8125
105,092.812
25.25
white
21.699219
15
0.694946
0.603882
28
0
0
yes
null
null
no dnr
35
105
10.798828
180
20
37.89844
640
3.099609
1.399902
0.799927
143
7.269531
102
6
2,750
0
0
SIP>=30
0
956
0
58.81198
female
0
6
Lung Cancer
Cancer
2
18
null
0
6,654
3,721.7891
4,312.9375
11
white
14.898438
6
0.759888
0.505981
1
0
0
metastatic
0.95
0.75
no dnr
6
117
11.5
80
9
39.29688
185
null
null
1.299805
144
7.489258
110
15
1,273
0
0
no(M2 and SIP pres)
0
152
1
74.11096
female
0
48
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
9
99,474
24,398.5625
97,995.375
26.5
white
41.296875
48
0.276978
0.168976
2
0
0
no
0.9
0.7
no dnr
48
83
3
100
20
36.69531
null
null
null
3.5
142
null
70
66
1,100
null
7
adl>=4 (>=5 if sur)
7
954
0
65.89197
female
0
5
MOSF w/Malig
ARF/MOSF
3
12
under $11k
0
13,944
4,423.6641
10,383.3125
33
white
26.597656
26
0.616943
0.512939
2
1
0
yes
null
null
no dnr
5
109
24.199219
113
24
36.39844
356
1.599854
26.796875
3.899902
150
7.419922
153
147
1,600
null
null
<2 mo. follow-up
2.152832
39
1
83.40295
male
0
18
CHF
COPD/CHF/Cirrhosis
2
null
null
0
44,009
24,023.8906
27,881.1719
24
white
19.398438
34
0.807983
0.688965
1
0
0
no
0.9
0.75
no dnr
18
54
9.5
145
12
38.79688
161.65625
2.599609
0.299988
0.699951
153
7.349609
144
26
3,155
null
null
null
3.135254
140
1
72.099
female
0
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
0
6,312
1,674.8115
6,128.40625
null
white
19.097656
36
0.796997
0.730957
2
0
0
yes
null
null
no dnr
3
54
4.699219
76
28
38.19531
107.5
2.599609
1
0.699951
141
7.439453
221
26
4,745
2
null
adl>=4 (>=5 if sur)
1.838867
98
1
72.81
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
$11-$25k
0
9,466
4,703.8672
6,218.63672
18
white
25.296875
51
0.703979
0.61499
1
1
0
yes
0.85
0.65
no dnr
6
110
7.699219
70
20
35.89844
114
3.599609
null
1.199951
146
7.259766
90
23
2,631
null
null
no(M2 and SIP pres)
2.320801
858
1
68.99896
female
0
8
Lung Cancer
Cancer
3
16
>$50k
0
11,272
6,130.332
6,395.29688
9.5
white
19.097656
23
0.652954
0.347961
1
0
0
metastatic
0.5
0.2
no dnr
8
137
7
56
50
37.89844
293.3125
null
null
0.799927
141
7.399414
166
20
1,610
2
2
<2 mo. follow-up
2
32
1
89.46997
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
>$50k
0
43,497
23,069.7344
24,701.7969
10
white
25.699219
32
0.616943
0.511963
5
0
0
no
0.7
0.7
dnr after sadm
1
97
10.398438
60
20
36.09375
131.65625
null
null
1.599854
143
7.30957
94
40
1,600
null
1
no(M2 and SIP pres)
1
611
1
45.741
male
0
23
Coma
Coma
3
8
under $11k
0
35,265
16,548.5625
24,172.3594
22.333328
white
23.699219
50
0.807983
0.770996
1
1
1
no
0.5
0.5
no dnr
23
139
10.599609
104
60
38.29688
297.5
2
0.299988
7.299805
140
7.359375
121
69
1,150
null
7
adl>=4 (>=5 if sur)
7
121
1
62.11899
male
0
9
COPD
COPD/CHF/Cirrhosis
3
17
$25-$50k
0
12,604
6,835.1055
7,271.77734
11
white
19.097656
17
0.855957
0.762939
1
0
0
yes
0.95
0.95
no dnr
9
55
12.398438
72
24
36.69531
240
3.399902
null
2.199707
145
7.529297
105
43
3,990
1
1
no(M2 and SIP pres)
1
947
0
86.75995
female
0
102
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
9
108,592
62,537.4062
64,422.0312
12.25
white
24
44
0.688965
0.596924
1
0
1
no
0.6
0.6
dnr after sadm
12
73
4.399414
130
30
36.09375
null
2
null
1.099854
145
null
281
25
null
null
2
null
2
238
1
82.12994
female
0
17
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
44,671
14,975.4922
39,899.2188
19
white
37.195313
55
0.232971
0.078995
14
0
0
no
0.75
0.66
dnr after sadm
6
39
13.599609
125
34
38.39844
148.96875
3.099609
1.399902
2.599609
136
7.359375
110
94
107
2
1
<2 mo. follow-up
1
52
1
64.01398
female
0
10
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
12,940
7,034.8008
6,696.66797
12.5
black
20.199219
30
0.866943
0.778931
1
0
0
no
0.9
0.8
no dnr
10
121
10.898438
106
12
38.29688
157
null
0.299988
0.799927
143
7.399414
145
12
1,625
2
1
no(M2 and SIP pres)
1
944
0
41.66498
male
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
null
0
71,676
39,046.6875
38,814.4688
33
black
36.898438
47
0.608887
0.50293
7
1
0
no
0.8
0.8
no dnr
23
107
6.599609
110
10
39.19531
190
null
null
1.199951
149
7.439453
136
18
4,890
null
0
no(M2 and SIP pres)
0
943
0
73.599
male
1
52
MOSF w/Malig
ARF/MOSF
1
16
$11-$25k
0
179,085
108,960
103,456.438
31.5
white
21.796875
34
0.56897
0.45697
20
0
0
metastatic
0.95
0.7
dnr after sadm
39
81
6.799805
76
20
37.39844
null
null
null
0.599976
137
null
115
10
4,202
null
0
<2 mo. follow-up
0
52
1
76.08795
male
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
null
0
45,370
20,808.0156
30,189.3906
27.333328
black
19.597656
35
0.829956
0.772949
1
0
0
no
0.85
0.6
dnr after sadm
7
47
5.799805
60
42
36.09375
80
2.899902
0.399963
0.299988
141
7.399414
102
3
3,195
null
0
<2 mo. follow-up
0
34
1